Vulnerability · Published Jun 13, 2023 · Assigned by BD
CVE-2022-47376
High 7.3
In plain English
A high-severity security flaw in Alaris Infusion Central. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.2% (higher than 5% of all known vulnerabilities).
Severity (CVSS 3.1)7.3High
Exploit odds (30 days)0.2%top 94.5% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| n/a | Alaris Infusion Central | <=1.3.2 |
Weakness: CWE-257 · Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L